Data Characteristics for This Category
Phase I clinical trial pharmacovigilance data comes primarily from Case Report Forms (CRFs), laboratory results, imaging reports, and follow-up records. This data typically exists in structured or semi-structured formats, such as CSV, JSON, or XML files. It might also reside in Clinical Data Management Systems (CDMS) or Electronic Health Records (EHR). Data updates are frequent during trials, potentially daily or weekly, especially when Adverse Events (AEs) or Serious Adverse Events (SAEs) occur. Key fields include Subject ID, AE Description, AE Onset/End Date, Severity, Relationship to Investigational Drug, Actions Taken, and Outcome. Units are usually international standard units, such as mol/L or mg/dL for laboratory indicators, and days or hours for time units.
Constraints from "HTTP Interface and External Systems"
The diverse and frequently updated nature of Phase I clinical data demands high real-time performance and stability from HTTP interfaces. Due to the urgency of adverse events, interfaces must support high-concurrency data writes and handle large volumes of structured and semi-structured data. Data documentation often includes detailed metadata definitions and field descriptions. This requires external systems to accurately map and validate data types, formats, and constraints during parsing. For example, the AE severity field might use enumerated values, and the relationship to investigational drug field might be a boolean or categorical value. Data volumes can range from several GB to tens of GB, challenging interface transmission efficiency and external storage system capacity. Error handling mechanisms need to be meticulous, as any data loss or error can impact subject safety and trial results.
Configuration Guidelines
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
batchSize | 100–500 records | Balances single request load and processing efficiency, preventing timeouts from excessively large requests. |
requestTimeout | 600 seconds | Accommodates large data volumes or unstable networks, preventing request interruptions. |
maxConnections | 50 | Ensures external systems respond promptly in high-concurrency scenarios, avoiding connection exhaustion. |
retryAttempts | 3 times | Addresses transient network fluctuations or temporary external system unavailability, improving data transfer success rates. |
dataEncoding | UTF-8 | Guarantees character set compatibility when describing adverse events in multiple languages, preventing garbled text. |
parseMode | JSON_STRICT | Phase I clinical data typically has a strict structure, ensuring data parsing accuracy. |
Common Pitfalls
- Receiving a
400 Bad Requesterror when calling the API. A common cause is incorrect handling of specific field types or formats required by the external system, such as date formats not conforming to ISO 8601. - Some fields are empty after data import. This might be because the data structure returned by the external system's interface does not match expectations, preventing the parser from correctly extracting the corresponding fields.
- Frequent
504 Gateway Timeouterrors during API calls. This usually indicates that the external system takes too long to process a single request and fails to respond in time, or there are bottlenecks in the network path.
Verification Steps
- Perform an end-to-end import test with a small amount of adverse event data. Verify that all key fields are correctly mapped and stored.
- Simulate a high-concurrency scenario. Write data at the maximum load using the configured
batchSizeandmaxConnections. Observe for5xxerrors or data loss. - Check the external system logs. Confirm no parsing errors or data validation failure warnings occurred during data transfer.
- Randomly select imported adverse event records. Compare them against the original data source to verify data completeness and accuracy, paying particular attention to sensitive fields like AE description and severity.
Note: The values provided are common starting points. Measure them against your own samples for optimal performance.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.